News Summary:
ANAHEIM, Calif. and MILFORD, Mass., June 3, 2024 /PRNewswire/ -- 72nd ASMS Conference on Mass Spectrometry and Allied Topics – Waters Corporation (NYSE: WAT) announced that more than 40 products within its liquid chromatography (LC) chemistry portfolio have obtained Accountability, Consistency, and Transparency (ACT) Ecolabels from My Green Lab, a nonprofit organization dedicated to building a global culture of sustainability in science. For more than 50 years, Waters has built a world-class reputation as a single-source manufacturer of LC column chemistries, with expertise in stationary phase synthesis, column hardware fabrication, and column packing.
"Today, sustainability is very much a part of our customers' decision-making process. Certifying Waters columns with ACT Ecolabels makes it easier for customers to make an environmentally conscious choice without having to sacrifice analytical performance and results," said Erin Chambers, Vice President, Consumables and Lab Automation, Waters Corporation. "We have always been committed to helping customers find the right chromatography column to solve their separation challenges. Over the years, innovations like MaxPeak™ Premier High-Performance Surfaces and CORTECS™ Solid Core Particles have delivered very high robustness and efficiency to the analytical laboratory. It is a real point of pride for us to be leading the way as the first vendor to provide ACT Ecolabels for our LC columns."
Waters offers a wide array of column choices and formats, including HPLC, UHPLC, GPC, SFC, and SEC, all built on reliable quality manufacturing that ensures that methods developed today will have the same repeatable results tomorrow.
Waters pioneered ultra performance liquid chromatography (UPLC) in 2004 with the launch of the ACQUITY™ UPLC™ Column, enabling the optimal use of sub 2-µm particles for the first time. With up to 9x faster separations and 80% reduction in solvent usage compared to HPLC, it is estimated that Waters ACQUITY UPLC Column and system users have saved more than 300 million hours of operational runtimei and 27 million liters of mobile phase.ii In addition, Waters is continuing to improve the sustainability of chromatography columns by redesigning packaging to replace the non-recyclable foam inserts with recycled and recyclable plastic and reducing column box sizes by 50%.iii
The Environmental Impact Factor (EIF) criteria, forming the basis for the ACT Ecolabel, was crafted with insights from scientists, sustainability directors, procurement specialists, and manufacturers. By emphasizing Accountability, Consistency, and Transparency (ACT) around manufacturing, energy and water use, packaging, and end-of-life, ACT makes it easy to choose more sustainable products. Waters ACQUITY and CORTECS Chromatography Columns are the first such products to earn the ACT Ecolabel from My Green Lab following a rigorous third-party verification process.
Additional Resources
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With approximately 7,700 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.
Waters, ACQUITY, CORTECS, MaxPeak, and UPLC are trademarks of Waters Technologies Corporation. ACT is a trademark of My Green Lab, Corp.
Contact:
Kevin Kempskie
Senior Director of Public Relations
Waters Corporation
This email address is being protected from spambots. You need JavaScript enabled to view it.
i Based on a 30-minute HPLC run vs. 10-minute UPLC run
ii HPLC 1.0 mL/min vs. UPLC 0.3 mL/min
iii References: Waters 2020 Sustainability Report, page 9
Last Trade: | US$357.77 |
Daily Change: | 13.06 3.79 |
Daily Volume: | 660,932 |
Market Cap: | US$21.240B |
November 07, 2024 November 01, 2024 October 10, 2024 October 08, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB